Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01470508
Other study ID # 10-0773
Secondary ID IRB# 10-0773K-23
Status Completed
Phase N/A
First received November 9, 2011
Last updated May 16, 2016
Start date August 2010
Est. completion date March 2016

Study information

Verified date May 2016
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority United States: Federal GovernmentUnited States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Promoviendo Alimentacion Saludable (PAS)"Promoting Healthy Eating" is a research project funded by the National Institute of Mental Health. The purpose of this study is to develop and test a treatment for eating disorders in Latina adults that is appropriate for their age and includes culturally appropriate family intervention.


Description:

Research on culturally sensitive assessment and treatment of eating disorders among Latinos is scarce. This study is comparing individual Cognitive Behavioral Therapy (CBT) versus CBT with a family adjunctive intervention for eating disorders in Latina adults. All treatment will be conducted by trained professionals from either the UNC Eating Disorders Program (in Chapel Hill) or from El Futuro, Inc. (in Carrboro or Durham, NC) who have been trained in the treatment of eating disorders.

Participants will participate in 25, 50 minute-long, face-to-face CBT sessions over 27 weeks. Participants will be randomly placed in one of two groups: CBT or CBT with family enhancement. Those participants who are randomly placed into the CBT group will participate in 25 individual therapy sessions, 3 sessions with a dietitian, and psychiatry and/or medical assessments as needed. Those participants who have been randomly placed into the CBT with family enhancement group will participate in 19 individual therapy sessions, 6 family therapy sessions, 3 sessions with a dietitian, and psychiatry and/or medical assessments as needed. All participants will also be expected to participate in baseline, week 6 (mid-treatment), end of treatment, and 3-month follow-up assessments.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date March 2016
Est. primary completion date March 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- DSM-IV criteria for BN, BED, EDNOS (sub-threshold BN)

- Latina

- If taking antidepressant medication, stable dose for at least 3 months prior

- Willingness to ask a family member or significant other to participate AND agreement of family member to participate

Exclusion Criteria:

- Any major medical condition that would interfere with treatment or require alternative treatment

- Alcohol or drug dependence in the last three months

- Current significant suicidal ideation

- Developmental disability that would impair the ability of the participant to benefit from psychotherapy effectively

- Psychosis, including schizophrenia, or bipolar I disorder

- Pregnancy

- Body mass index below 17.5 kg/m^2

- If taking antidepressant medication, doses are not stable; individuals taking any medications that can significantly affect appetite or weight.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive Behavioral Therapy
Individuals meet with a therapist once a week for 25 sessions, 50 minutes in length, for a period of 27 weeks for therapy. Cognitive Behavioral Therapy is manualized and is the standard form of care at the UNC Eating Disorders Program.
Cognitive Behavioral Therapy with Family Enhancement
Individuals will meet with a therapist once a week for 25 sessions, 50 minutes in length, for a period of 27 weeks for therapy. Cognitive Behavioral Therapy with Family Enhancement is manualized and will involve the participation of family members during six (6) weeks of treatment.

Locations

Country Name City State
United States UNC Center of Excellence for Eating Disorders Chapel Hill North Carolina
United States University of North Carolina Chapel Hill North Carolina

Sponsors (4)

Lead Sponsor Collaborator
Mae Lynn Reyes-Rodriguez, PhD El Futuro, National Institute of Mental Health (NIMH), University of North Carolina, Chapel Hill

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other M-FED Questionnaire 3 Month Follow-up No
Primary Change from Baseline in Eating Disorder Examination (EDE) Scores at End of Treatment End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. Baseline, End of Treatment No
Secondary Change from Baseline in Beck Depression Inventory-Revised (BDI-R) score at Week 6 of Treatment Baseline, Week 6 No
Secondary Change from Baseline in Beck Depression Inventory-Revised (BDI-R) score at End of Treatment End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. Baseline, End of Treatment No
Secondary Change from Baseline in Beck Depression Inventory-Revised (BDI-R) score at 3 Month Follow-up Baseline, 3 Month Follow-up No
Secondary Change from Baseline in the Symptom Checklist-36 (SCL-36) score at Week 6 of Treatment Baseline, Week 6 of Treatment No
Secondary Change from Baseline in Symptom Checklist-36 (SCL-36) score at End of Treatment End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. Baseline, End of Treatment No
Secondary Change from Baseline in Symptom Checklist-36 (SCL-36) score at 3 Month Follow-up Baseline, 3 Month Follow-up No
Secondary Change from Baseline in Family Support Questionnaire score at End of Treatment End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. Baseline, End of Treatment No
Secondary Change from Baseline in Family Support Questionnaire score at 3 Month Follow-up Baseline, 3 Month Followup No
Secondary Change from Baseline in Family Cohesion (FC) score at End of Treatment End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. Baseline, End of Treatment No
Secondary Change from Baseline in Family Cohesion (FC) score at 3 Month Follow-up Baseline, 3 Month Follow-up No
Secondary Change from Baseline in Family Burden Interview Scale (FBIS) score at End of Treatment End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. Baseline, End of Treatment No
Secondary Change from Baseline in Family Burden Interview Scale (FBIS) score at 3 Month Follow-up Baseline, 3 Month Follow-up No
Secondary Change from Baseline in Family Score (FS) at End of Treatment Baseline, End of Treatment No
Secondary Change from Baseline in Family Score (FS) at 3 Month Follow-up Baseline, 3 Month Follow-up No
Secondary Treatment Adherence as of End of Treatment Treatment Adherence will be measured positively if a participant has completed at least 80% of treatment (20 sessions or more) or negatively if less than 80% of treatment (19 sessions or less) has been completed. Baseline, End of Treatment No
Secondary Change from Baseline in Eating Disorder Examination Questionnaire (EDE-Q) score at Week 6 of Treatment Baseline, Week 6 No
Secondary Change from Baseline in Eating Disorder Examination Questionnaire (EDE-Q) score at End of Treatment End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. Baseline, End of Treatment No
Secondary Change from Baseline in Eating Disorder Examination Questionnaire (EDE-Q) score at 3 Month Follow-up Baseline, 3 Month Follow-up No
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04174703 - Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing N/A
Terminated NCT04278755 - Binge Eating & Birth Control Phase 2
Withdrawn NCT02978742 - Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder N/A
Withdrawn NCT00988481 - Topiramate Augmentation in Bulimia Nervosa Partial Responders Phase 4
Completed NCT00522769 - Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents Phase 1/Phase 2
Completed NCT00184301 - A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder. N/A
Completed NCT00304187 - Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa Phase 2
Recruiting NCT04409457 - Self-Control in Bulimia Nervosa N/A
Recruiting NCT05509257 - Naltrexone Neuroimaging in Teens With Eating Disorders Early Phase 1
Recruiting NCT05937243 - Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating N/A
Recruiting NCT05862389 - Study on the Mechanism of Eating Disorder
Recruiting NCT05728021 - Smartphone-based Aftercare for Inpatients With Bulimia Nervosa N/A
Completed NCT03781921 - The Neural Bases of Emotion Regulation in Bulimia Nervosa
Completed NCT02553824 - FDA Approved Medication to Reduce Binge Eating and/or Purging Phase 1
Terminated NCT04041024 - Decision-making and Risk-taking in Bulimia N/A
Completed NCT04265131 - Emotion Regulation in Eating Disorders: How Can Art Therapy Contribute to Treatment Outcome? N/A
Recruiting NCT06431854 - Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program N/A
Recruiting NCT02960152 - Periodontal Impact of Eating Disorders (the PERIOED Study) N/A
Completed NCT00916071 - Association Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating Disorders N/A
Terminated NCT00308776 - Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa N/A